Design of a multicenter randomized trial for the stroke prevention in atrial fibrillation study

Stroke

Volumn 21, Issue 4, 1990, Pages 538-545

  Anderson, David C ^a   Asinger, Richard W ^a   Newburg, Susan M ^a   Farmer, Cheryl C ^a   Wang, K ^a   Bundlie, Scott R ^a   Koller, Richard L ^a   Jagiella, Waclav M ^a   Kreher, Susan ^a   Jorgensen, Charles R ^a   Sharkey, Scott W ^a   Flaker, Greg C ^b   Webel, Richard ^b   Nolte, Barbie ^b   Stevenson, Pat ^b   Byer, John ^b   Wright, William ^b   Chesebro, James H ^r   Wiebers, David O ^c   Holland, Anne E ^c   Miller, Diane M ^c   Bardsley, William T ^c   Litin, Scott C ^c   Zerbe, Douglas M ^c   McAnulty, John H ^d   Marchant, Christy ^d   Coull, Bruce M ^d   Feldman, George ^e   Hayward, Arthur ^e   Gandara, Elizabeth ^e   Blank, Nathan ^e   Leonard, Anne D ^f   Easton, Carann A ^f   Chanc, John ^f   Easton, J Donald ^f   Kanter, Merrill C ^f   Kopecky, Steven L ^f   Isensee, Laura M ^f   Quiroga, Elia S ^f   Presti, Charles H ^f   Tegeler, Charles H ^f   Logan, William R ^g   Hamilton, William P ^g   Bacon, Rebecca S ^g   Green, Barbara J ^g   Buckingham, Thomas A ^h   Cadell, Dorothy J ^h   Gomez, Camilo R ^h   Janosik, Denise L ^h   Redd, Robert M ^h   Labovit, Arthur J ^h   Kelley, Roger E ⁱ   Chahine, Robert ⁱ   Cristo, Lillian ⁱ   Palermo, Maite ⁱ   Perez, Odalys ⁱ   Pina, Iliana ⁱ   Feinberg, William M ^j   Void, Brenda K ^j   Kern, Karl B ^j   Appleton, Christopher ^j   Miller, Vincent T ^k   Hockersmith, Connie J ^k   Cohen, Bruce A ^k   Martin, Gary J ^k   Pawlow, Alan J ^k   Halperin, Jonathan L ^l   Rothlauf, Elizabeth B ^l   Weinberger, Jesse M ^l   Goldman, Martin E ^l   Goldman, Richard ^l   Fuster, Valentin ^l   Dittrich, Howard C ^m   Rothrock, Johnf ^m   Hagenhoff, Carol ^m   Helgason, Cathy M ⁿ   Kondos, George T ⁿ   Kaufmann, Lisa ⁿ   Hoff, Julie ⁿ   Rabjohns, R R ⁿ   McRae, R P ⁿ   Ghali, J ⁿ   Adams, Harold P ^o   Theilen, Ernest O ^o   Biller, José ^o   Brown, Donald D ^o   Marsh, Ellis Eugene ^o   Sirna, Sara J ^o   Mitchell, Victoria L ^o   Rothbart, Robert M ^p   Bailey, Gretchen H ^p   Burkhardt, Carolyn ^p   Horn, Gage Van ^q   Nacarelli, Gerald V ^q   Wilson, Deborah Grimm ^q   McBride, Ruth ^q   more..

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c MAYO CLINIC   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e KAISER PERMANENTE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g ST JOHN S MERCY MEDICAL CENTER   (United States)

^h S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l MOUNT SINAI MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF ILLINOIS   (United States)

^o UNIVERSITY OF IOWA   (United States)

^p UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF TEXAS   (United States)

^r NONE

more..

Author keywords

Anticoagulants; Atrial; Clinical; Embolism; Fibrillation; Trials

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; HUMAN; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STATISTICS; SUPPORT, U.S. GOV'T, P.H.S.; WARFARIN;

EID: 0025308180     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.21.4.538     Document Type: Article

References (39)

1. Ostrander LD, Brandt RL, Kjelsbcrg MO, Epstein FH: Electrocardiographic findings among the adult papulation of a total natural community. Tecumseh, Michigan. Circulation 1965;31:888-898
2. Martin A: Atrial fibrillation in the elderly. Br Med J 1977;1:712-716
3. Svareborg A: Seventy-year-old people in Gothenberg: A population study in an industrialized Swedish city. Acta Med Scand 1977;611 (suppl):5-37
4. Olsson SB: Atrial fibrillation - Some current problems. Acta Med Scand 1980;207:1-4
5. Kannel WB, Abbott RD, Savage DD, McNamara PM: Epidemiologic features of chronic atrial fibrillation: The Framingham Study, N Engl J Med 1982;306:1018-1022
6. Wolf PA, Dawber TR, Thamer HE Jr, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology (NY) 1978; 28:973-977
7. Hinton RC, Kistler P, Fallon JR, Friedlich AL, Fisher CM: Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977;40:509-513
8. Fisher CM: Reducing risks of cerebral embolism. Geriatrics 1979;34:59-66
9. Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton D: Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984;41:708-710
10. Aberg H: Atrial fibrillation: A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969;185:373-379
11. Hart RG, Coull BM, Hart PD: Early recurrent embolism associated with nonvalvular atrial fibrillation. Stroke 1983; 14:688-693
12. Britton M, Gustafson C: Nonrheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985;16:182-188
13. Roy D, Marchand E, Gagne P, Chabot M, Cartier R: Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986; 112:1139-1143
14. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1989;1:175-179
15. Wolf PA. Abbott RD, Kannel WB: Atrial fibrillation: A major contributor to stroke in the elderly. Arch Intern Med 1987; 147:1561-1564
16. Aronow WS, Gutstein H, Hsieh FY: Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 1989;63:366-367
17. Yuen RWM, Gutteridge DH, Thompson PL, Robinson JS: Embolism in thyrotoxic atrial fibrillation. Med J Aust 1979; 1:630-631
18. Hurley DM, Hunter AN, Hewett MJ, Stoekigt JR: Atrial fibrillation and arterial embolism in hyperthyroidism. Aust NZ J Med 1981;11:391-393
19. Wiener I: Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation. Am J Cardiol 1987;59:177
20. Hart RG, Easton JD, Sherman DG: Duration of nonvalvular atrial fibrillation and stroke (letter). Stroke 1983;14:827
21. Wolf PA, Kannel WB, McGee DL: Duration of atrial fibrillation and imminence of stroke: The Framingham Study. Stroke 1983;14:664-667
22. Ruocco NA, Most AS: Clinical and echocardiographic risk factors for systemic embolization in patients with atrial fibrillation in the absence of mitral stenosis (abstract). J Am Coll Cardiol 1986;7:165
23. Caplan LR, D’Cruz I, Hier DB, Reddy H, Shah S: Atrial size, atrial fibrillation and stroke. Ann Neurol 1986;19:158-161
24. Sage JI, Van Uitert RL: Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke 1983;14:537-540
25. Sherman DG, Hart RG, Easton JD: The secondary prevention of stroke in patients with atrial fibrillation. Arch Neurol 1986;3:68-70
26. Lodder J, Krijne-Kubat B, Broekman J: Cerebral hemorrhagic infarction at autopsy: Cardiac embolic cause and the relationship to the cause of death. Stroke 1986;17:626-629
27. Close JB, Evans DW, Bailey SM: Persistent lone atrial fibrillation; its prognosis after clinical diagnosis, J Coll Gen Pract 1979;29:547-549
28. Kopecky SL, Gerah BJ, McGoon MD: The natural history of lone atrial fibrillation. N Engl J Med 1987;317:669-674
29. Onundarson FT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T: Chronic atrial fibrillation: Epidemiologic features and 14 year follow-up: A case-control study. Eur Heart J 1987;8:521-527
30. Davidson E, Rotenberg Z, Weinberger I, Fuchs J, Agman J: Diagnoses and characteristics of lone atrial fibrillation. Chest 1989;95:1048-1050
31. Takahasi N, Seki A, Iwataka K, Fujii J: Clinical features of paroxysmal atrial fibrillation: An observation of 94 patients. Jpn Heart J 1981;22:143-149
32. Fortin AH, Isner JM: Should patients with paroxysmal atrial fibrillation receive prophylactic anticoagulants? (abstract). J Am Coll Cardiol 1983;1:704
33. Petersen P, Godtfredsen J: Embolic complications in paroxysmal atrial fibrillation. Stroke 1986;17:622-626
34. Jette A, Deniston OL: Inter-observer reliability of the functional status assessment instrument. J Chronic Dis 1978; 31:573-589
35. Jacobs JW, Bernhard MR, Delgado A, Strain JJ: Screening for organic mental syndromes. Ann intern Med 1977;86:40-46
36. Norris JW: Comment on “Study Design of Stroke Treatments.” Stroke 1982;13:527-529
37. Haynes RB, Mukherjee J, Sackett DL, Taylor DW, Barnett HJM, Peerless SJ, EC-IC Bypass Study Group: Functional status changes following medical or surgical treatment for cerebral ischemia. JAMA 1987;257:2043-2046
38. Rubinstein LV, Gail MH, Santner TJ: Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Dis 1981; 34:469-479
39. Fleming TR, Harrington D, O’Brien P: Designs for group sequential trials. Controlled Clin Trials 1984;5:348-361